The correlation between serum calcium and asprosin in elderly patients with type 2 diabetes mellitus in community - Report - MDSpire

The correlation between serum calcium and asprosin in elderly patients with type 2 diabetes mellitus in community

  • By

  • Dong Liang

  • Huimin He

  • Zhengqian Wang

  • Chunfan Niu

  • Yan Wang

  • Linxin Xu

  • Jing Yang

  • June 9, 2026

  • 0 min

Share

Clinical Report: Association of Serum Calcium and Asprosin Levels in Older Adults

Overview

This study investigates the relationship between serum calcium and asprosin levels in elderly patients with type 2 diabetes mellitus (T2D). It identifies significant associations between these biomarkers and various metabolic indicators.

Background

The increasing prevalence of type 2 diabetes mellitus (T2D) among the elderly poses significant public health challenges, particularly in managing metabolic disorders and cardiovascular risks. Calcium homeostasis and adipokine metabolism are critical factors in the progression of T2D and its complications.

Data Highlights

IndicatorCorrelation Coefficient (r)p-value
HDL-C0.123-
Uric Acid0.132-
Asprosin0.124-
Creatinine-0.113-
Total Calcium0.214< 0.001
Albumin-Corrected Calcium0.1700.002

Key Findings

  • Serum asprosin levels increased progressively across serum calcium tertiles.
  • Statistically significant associations were found between serum calcium and HDL-C, uric acid, asprosin, and creatinine.
  • In multivariable linear regression, creatinine and asprosin were independently associated with serum calcium levels.
  • A significant positive correlation was observed between serum asprosin and total calcium.

Clinical Implications

The findings suggest that monitoring serum asprosin and calcium levels may be important in managing elderly patients with T2D. Understanding these associations could inform clinical strategies aimed at addressing metabolic and cardiovascular risks in this population.

Conclusion

The study establishes a significant independent association between serum asprosin and calcium levels in elderly patients with T2D.

Related Resources & Content

  1. Frontiers in Endocrinology, 2026 -- Serum 25-hydroxyvitamin D is associated with islet function in postmenopausal women with type 2 diabetes and osteoporosis
  2. Frontiers in Endocrinology, 2026 -- Association of 25(OH)D status with calcium metabolism, inflammation, and thyroid autoimmunity in patients with type 2 diabetes mellitus
  3. The Journal of Clinical Endocrinology & Metabolism -- Increased Urinary Calcium Levels Correlate with Reduced Bone Development in Young Individuals with Type 1 Diabetes
  4. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  5. Frontiers | The correlation between serum asprosin and type 2 diabetic patients with obesity in the community
  6. Association of serum calcium levels with diabetic kidney disease in normocalcemic type 2 diabetes patients: a cross-sectional study | Scientific Reports
  7. The Journal of Clinical Endocrinology & Metabolism — Bone Microstructure in Elderly Men with Type 2 Diabetes: Significance of Bone Dimensions
  8. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  9. Frontiers | The correlation between serum asprosin and type 2 diabetic patients with obesity in the community
  10. Association of serum calcium levels with diabetic kidney disease in normocalcemic type 2 diabetes patients: a cross-sectional study | Scientific Reports

Original Source(s)

Related Content